Advocacy
73 articles
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Research Suggests Twitter as a Powerful Tool to Drive Awareness about Pancreatic Cancer
Research analysis of PancChat shows the power of the Twitter chat to raise awareness about pancreatic cancer.
New Pancreatic Cancer Public Service Announcement
Let’s Win and the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation announce a joint public service announcement in a press release.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
A Platinum Remembrance: The Power of Raising Your Voice
Gil Bashe and John Bianchi share a remembrance of Anne Glauber’s work and the power of advocacy on the eve of the Platinum PR Awards.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Mary Fisher
The world “discovered” Mary Fisher on the evening of August 19, 1992, when she delivered a speech at the 1992 Republican Convention. It is ranked as one of the 100 greatest American speeches in the 20th Century. Since the steaming night in Houston, the world has come to know Mary as a gifted artist, a […]
Living with Pancreatic Cancer as a Long-Term Survivor
Roberta Luna has been fighting pancreatic cancer since 2002, but the disease has been part of her life for much longer. Read about her battle.
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
Changing Course Midstream
Barbara Green wasn’t happy with her doctors, so she took the advice of her support group, was an advocate for herself, and changed doctors.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Advocating For My Own Future
Kay Kays is a long-term survivor of pancreatic cancer who has learned to advocate for herself to get the treatments she needs.
PRECEDE Trial Sets Survival Rate Goal
Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s goal to increase pancreatic cancer survival rates.
Artificial Intelligence and Early Detection of Pancreatic Cancer
How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.